<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Short daily hemodialysis</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Short daily hemodialysis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Short daily hemodialysis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Gihad E Nesrallah, MD, MSc, FRCPC</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Robert M Lindsay, MD, MB,ChB, FRCPC, FRCP(Edin), FRCP(Glas), FACP</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Steve J Schwab, MD, FACP, FASN</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Eric N Taylor, MD, MSc, FASN</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> May 26, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>The first successful use of short daily or "quotidian" hemodialysis was first reported by DePalma in 1969 [<a href="#rid1">1,2</a>]. This approach was based upon the premise that improved patient outcomes, compared with conventional three times per week hemodialysis, would occur with a dialysis schedule that consisted of the same number of hours of dialysis per week but delivered over twice as many sessions. More specifically, this schedule consists of daily hemodialysis (five to seven days per week) provided for a duration of 1.5 to 3 or more hours per session.</p><p>Initial attempts to popularize daily dialysis in the United States were thwarted by financial and logistical issues. This led to a decline in its use both in the home and in-center settings.</p><p>Over the last decade, however, there has been a resurgence in the use of daily dialysis, with several studies emerging from the United States and Europe showing improvements in various physiologic and clinical outcomes. In the wake of the Hemodialysis (HEMO) study, which found no overall survival benefit with high- versus low-flux hemodialysis, attention turned from increasing per-session small solute clearance to altering treatment frequency and/or duration [<a href="#rid3">3,4</a>]. </p><p>Increasing availability and acceptability of daily home hemodialysis (HHD) has contributed to the recent increase in home dialysis use in the United States and other high-income countries. Between 2009 and 2019, the cumulative incidence of home dialysis within the first year of dialysis initiation increased from 10.5 to 18 percent, with a point-prevalent rate of 13 percent for home dialysis among all patients on kidney replacement therapy. Although peritoneal dialysis was the dominant form of home dialysis (11.2 percent), among the 1.9 percent of patients on home hemodialysis in the United States in 2019, 39.1 percent were prescribed at least 3.5 and 38 percent at least 5 sessions per week, making more frequent dialysis the most common form of HHD in the United States, mainly using a low dialysate volume approach (NxStage).</p><p>Daily dialysis has also been proposed as a rescue therapy and in the intensive care unit (ICU) setting [<a href="#rid5">5,6</a>] (see  <a class="medical medical_review" href="/d/html/1903.html" rel="external">"Prolonged intermittent kidney replacement therapy"</a>). Short daily hemofiltration and hemodiafiltration have also been introduced, being used both in center and at home [<a href="#rid7">7,8</a>]. The 2015 Kidney Disease Outcomes Quality Initiative (KDOQI) guidelines suggest offering in-center short daily hemodialysis as an alternative to conventional hemodialysis [<a href="#rid9">9</a>].</p><p>This topic review will discuss short daily hemodialysis. A review of long daily or nocturnal hemodialysis is presented separately. (See  <a class="medical medical_review" href="/d/html/1904.html" rel="external">"Technical aspects of nocturnal hemodialysis"</a>.)</p><p>A review of home hemodialysis using a low-dialysate volume approach (ie, NxStage) is discussed elsewhere. (See  <a class="medical medical_review" href="/d/html/14021.html" rel="external">"Short daily home hemodialysis: The low dialysate volume approach"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">OVERVIEW OF RATIONALE</span><span class="headingEndMark"> — </span>The rationale for short daily hemodialysis is based upon a strategy that is proposed to enhance both dialysis efficiency and hemodynamic stability.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Improved dialysis efficiency </strong>– The exponential decrease in the serum concentration of small molecules, such as urea, during hemodialysis leads to dissipation of the blood-to-dialysate gradient and to reduced efficiency of small molecule removal over time [<a href="#rid10">10</a>]. With short daily dialysis, shortening the dialysis time while increasing the frequency of dialysis allows more time to be spent dialyzing against higher uremic solute concentration gradients. This enhances the efficiency of solute removal. Ultimately, a new steady state with lower peak but higher trough solute concentrations is achieved.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Improved hemodynamic stability </strong>– More frequent dialysis allows for less interdialytic fluid accumulation. This is likely to improve hemodynamic stability during dialysis, with increased potential for normalizing the extracellular fluid volume (ECFV).</p><p></p><p class="headingAnchor" id="H5"><span class="h1">MEASURES OF ADEQUACY</span><span class="headingEndMark"> — </span>Traditional urea kinetic modeling, as validated for conventional (three times weekly) hemodialysis, cannot be directly applied to the assessment of dialysis adequacy with frequent (short daily or nocturnal) dialysis regimens. (See  <a class="medical medical_review" href="/d/html/1836.html" rel="external">"Prescribing and assessing adequate hemodialysis"</a> and  <a class="medical medical_review" href="/d/html/1904.html" rel="external">"Technical aspects of nocturnal hemodialysis"</a>.)</p><p>The need for a universal dose measure applicable to all modalities that may correlate with patient outcomes has therefore led to standard weekly Kt/V (stdKt/V) being the measure of adequacy. The stdKt/V is more widely utilized than other methods and is calculated based upon the midweek predialysis urea rather than the time-averaged concentration (TAC) of urea [<a href="#rid11">11</a>]. The minimum recommended dialysis dose, which follows the current Dialysis Outcomes Quality Initiative (DOQI) guidelines, is a stdKt/V value of approximately 2 per week for all dialysis methods. A weekly stdKt/V of 2 is provided by a daily dose with an equilibrated Kt/V (eKt/V) of 0.38 (less than one-half of the required dose of 1.05 with conventional hemodialysis).</p><p>Compared with conventional dialysis, however, the same number of hours per week of daily dialysis results in lower predialysis urea values. Thus, current daily short hemodialysis provides a higher stdKt/V of approximately 3 [<a href="#rid12">12,13</a>].</p><p>How well any of these measures correlate with clinical outcomes is currently unclear.</p><p class="headingAnchor" id="H6"><span class="h1">PRACTICAL ASPECTS OF DAILY HEMODIALYSIS DELIVERY</span><span class="headingEndMark"> — </span>General features of and prerequisites for a home dialysis program are discussed separately (see  <a class="medical medical_review" href="/d/html/1875.html" rel="external">"Home hemodialysis (HHD): Establishment of a program"</a>) [<a href="#rid14">14</a>]. The following section elaborates on some of the technical and logistical details of daily dialysis delivery with a focus on the home setting.</p><p class="headingAnchor" id="H7"><span class="h2">Patient recruitment and selection</span><span class="headingEndMark"> — </span>To date, there are no evidence-based recommendations to guide patient selection for home daily dialysis. In practice environments where resources limit its use, daily dialysis should be prescribed on the basis of need, such as the management of refractory uremic complications, fluid overload, resistant hypertension, or intradialytic hypotension.</p><p>Until large-scale comparative studies are available, the selection of nocturnal versus short daily dialysis should largely be dictated by availability and patient preference, although patients with particularly difficult to manage hyperphosphatemia clearly benefit more from the longer treatment time conferred by nocturnal therapy. Where resources are not limited and in the absence of contraindications, patient willingness remains the primary criterion for selection for daily dialysis. Significant barriers to home-based therapy include decreased compliance, cognitive ability, visual acuity, and/or motor skills and/or a lack of an assistant.</p><p>Center-based daily hemodialysis may be reserved for those in greatest medical need or for volunteers ardently seeking improved quality of life or functional status. Patients with high levels of comorbidity and those with hemodynamic instability or seizure disorders are better suited to the supervised in-center environment.</p><p>For center-based therapy, patient proximity to the dialysis unit and availability of transportation may be important limiting factors. However, this does not mean that the use of daily dialysis as a form of "rescue therapy" for medical reasons cannot be considered in patients with geographic limitations (if even for shorter periods of time).</p><p class="headingAnchor" id="H8"><span class="h2">Training and education for a home daily hemodialysis patient</span><span class="headingEndMark"> — </span>Training usually requires a full-time six-week commitment, although two weeks can be sufficient for a patient with self-care experience. Training focuses on the use of the dialysis machine, troubleshooting alarms, adjusting treatment parameters (including dialysate composition), dealing with emergencies (eg, air embolism, accidental disconnection from the blood circuit), and proper vascular access cannulation/connection technique. It is also important to include machine and water treatment maintenance, supply management, medication self-administration, and laboratory sampling in the training schedule [<a href="#rid15">15</a>].</p><p>Patient training for daily hemodialysis was compared with those undergoing conventional hemodialysis in the London Daily/Nocturnal Hemodialysis Study of 11, 12, and 22 patients undergoing short daily, nocturnal, and conventional hemodialysis, respectively [<a href="#rid15">15</a>]. The average patient training period was approximately 17 days, with patients using native arteriovenous fistulae (AVF), grafts, or central catheters.</p><p class="headingAnchor" id="H9"><span class="h2">Vascular access</span><span class="headingEndMark"> — </span>Native AVF, synthetic grafts, and long-term central venous catheters (CVCs) are all acceptable for use in daily hemodialysis, with the same order of preference as for conventional dialysis. Similarly, needles suitable for conventional dialysis can be used for daily dialysis.</p><p>Patient comfort and AVF longevity may be increased by using the buttonhole technique, which involves re-cannulation of the same two or three sites on a rotating basis [<a href="#rid16">16-18</a>]. Using this method, the needle/cannula is inserted through exactly the same hole at the same angle and depth of penetration [<a href="#rid18">18-20</a>]. After 8 to 10 cannulations (or 12 to 14 in diabetic patients), an epithelialized track develops that allows the use of blunt needles [<a href="#rid18">18</a>].</p><p>Buttonhole cannulation without the use of local <a class="drug drug_general" data-topicid="9668" href="/d/drug information/9668.html" rel="external">mupirocin</a> can be associated with <em>Staphylococcus aureus</em> bacteremia, often leading to life-threatening metastatic infections. The risk of infection was examined in the following studies:</p><p class="bulletIndent1"><span class="glyph">●</span>A randomized trial compared 140 conventional hemodialysis patients assigned to either the buttonhole technique or to conventional "rope-ladder" needling [<a href="#rid21">21</a>]. At eight weeks, the rate of localized infection was higher among patients assigned to the buttonhole technique compared with conventional needling (50 versus 22.4 per 1000, respectively). There was one episode of <em>S. aureus</em> bacteremia at eight weeks and two more episodes after the study ended but within 12 months in the group utilizing the buttonhole technique versus none in the conventional needling group. At 12 months, the number of needling site abscesses requiring intravenous (IV) antibiotics was higher in the buttonhole group versus the conventional needling group (nine versus zero, respectively). The degree to which these data from conventional hemodialysis patients may be extrapolated to nocturnal daily hemodialysis or self-cannulating patients is not clear [<a href="#rid22">22</a>]. (See  <a class="medical medical_review" href="/d/html/112108.html" rel="external">"Overview of hemodialysis arteriovenous fistula maintenance and thrombosis prevention", section on 'Standard versus buttonhole technique'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A retrospective review analysis compared the buttonhole technique with rope-ladder cannulation among 90 consecutive home hemodialysis patients [<a href="#rid23">23</a>]. Over 3765 AVF-months, there were 17 systemic infections attributed to fistula infections. Compared with rope-ladder cannulation, the buttonhole technique was associated with a higher rate of total fistula infections (incidence rate ratio [IRR] 3.85, 95% CI 1.66-12.77) but not systemic infections. Loss of the fistula or requirement for surgical intervention was not different between the groups, although interventions by radiology were not included in the analysis [<a href="#rid24">24</a>].</p><p></p><p class="bulletIndent1">An accompanying systematic review also found an increased risk of infections associated with buttonhole technique compared with other techniques in four randomized trials (relative risk [RR] 3.34, 95% CI 0.91-12.20), as well as in observational studies.</p><p></p><p>As a result of the increased risk of infection, avoidance of buttonhole cannulation has been advocated by some experts. We have not seen any cases of <em>S. aureus</em> bacteremia in our center since adopting <a class="drug drug_general" data-topicid="9668" href="/d/drug information/9668.html" rel="external">mupirocin</a> prophylaxis. Most centers do not practice the buttonhole technique for facility-based dialysis.</p><p>The buttonhole technique may be associated with fewer thrombotic complications. In the Frequent Hemodialysis Network (FHN) trial, in which 245 patients were randomly assigned to receive in-center six days per week hemodialysis or conventional three days per week hemodialysis, compared with the rope-ladder technique, the buttonhole technique was associated with longer intervals between access-related events (hazard ratio [HR] 0.44, 95% CI 0.20-0.97) [<a href="#rid25">25</a>]. This benefit was driven mostly by a reduction in thrombotic episodes. The buttonhole technique may also improve fistula survival among patients undergoing conventional hemodialysis [<a href="#rid26">26</a>]. (See  <a class="medical medical_review" href="/d/html/112108.html" rel="external">"Overview of hemodialysis arteriovenous fistula maintenance and thrombosis prevention", section on 'Standard versus buttonhole technique'</a>.)</p><p>Irrespective of technique (ie, buttonhole versus rope ladder), more frequent cannulation may lead to more frequent access-related complications, and regular clinical assessment of the AV access should be part of routine follow-up for patients on hemodialysis in any care setting. (See <a class="local">'Vascular access'</a> below.)</p><p class="headingAnchor" id="H10"><span class="h2">Equipment and technical aspects</span><span class="headingEndMark"> — </span>It is important to establish standardized technical requirements that incorporate the assessment of the patient's home and implications for installation planning and home renovations, if required. The dialysis machines approved for home hemodialysis in the United States include the Fresenius 2008@Home, NxStage System One and One S, and Outset Medical Tablo [<a href="#rid14">14</a>].</p><p>The proliferation of home hemodialysis has led to the production of dialysis machines specifically designed for home use. In general, these machines should be simple to use, compact, and quiet, with easily accessible controls. A review of the different dialysis machines currently available for the home can be found elsewhere. (See  <a class="medical medical_review" href="/d/html/1874.html" rel="external">"Choosing home hemodialysis for end-stage kidney disease"</a>.)</p><p>Appropriate water treatment must be provided to the home. Initial water samples for chemical content and bacteria are needed to determine water treatment requirements. These may be different for rural patients on well water versus those in an urban area on municipal water. (See  <a class="medical medical_review" href="/d/html/1896.html" rel="external">"Assuring water quality for hemodialysis", section on 'Home hemodialysis'</a>.)</p><p>There are essentially two types of water treatment systems: reverse osmosis (RO) and deionization (DI) systems. The choice of either a RO or DI water system should be determined by a program policy that factors in capital equipment costs, operating costs, water system support and service, patient training responsibility, and system safety and reliability. Most centers use RO water systems as they are less costly to operate after the initial higher cost of purchase.</p><p>A suitable RO system for home use must be small and quiet and must be compatible with the patient's dialysis machine. The configuration of the patient's home should be considered when choosing a purification system. For daily dialysis, the water treatment system can be located in the room adjacent to the dialysis machine as noise levels may not be so important (as compared with nocturnal dialysis, where sleep can be affected by noise).</p><p>With respect to in-center dialysis, the ideal dialysis equipment should provide quick patient turnaround to help with scheduling, although any equipment can be used. Having additional machines on hand can reduce down time between treatments by enabling setup and priming to occur asynchronously.</p><p>Additional details of the technical requirements of home hemodialysis programs with full references can be found elsewhere [<a href="#rid27">27</a>].</p><p class="headingAnchor" id="H11"><span class="h2">Dialyzer selection</span><span class="headingEndMark"> — </span>Membrane selection for daily hemodialysis is the same as for conventional hemodialysis, and synthetic, high-flux membranes are typically used. </p><p class="headingAnchor" id="H12"><span class="h2">Dialysis prescription and dose monitoring</span><span class="headingEndMark"> — </span>As previously mentioned, the optimal method of prescribing and monitoring the dose of daily hemodialysis regimens is not established. Some method of dose quantification is necessary to guide individual patient prescriptions, to monitor adequate dialysis delivery, and to allow patient outcome comparisons between the various dialysis regimens.</p><p>Based upon mathematical modeling, a per-session equilibrated Kt/V (eKt/V) of 0.37 (single-pool Kt/V [spKt/V] of 0.53 to 0.56) delivered using a short daily hemodialysis regimen is roughly equivalent to conventional hemodialysis with a per-session eKt/V of 1.05 [<a href="#rid28">28</a>]. This should be considered a minimum acceptable dose when using short daily dialysis.</p><p>In our opinion, however, a weekly standardized Kt/V (stdKt/V) target of 3 should be sought, as was achieved in the London Daily/Nocturnal Study [<a href="#rid12">12</a>]. This dose was associated with improvements in a number of physiologic parameters (as noted in the next section) and allows for a margin of safety in case the prescribed dose is not fully delivered. This is equivalent to a weekly spKt/V of 5.6, a per-session spKt/V of 0.93, or a sessional eKt/V of 0.82.</p><p>Modeling indicates that this target is likely to be achievable with a 2.5 hour, six day per week regimen in 95 percent of patients [<a href="#rid29">29</a>]. In the London Study, the delivered dose was achieved using high-flux, large surface area dialyzers (eg, F80, Optiflux 160 or 200) with dialyzer blood flow rates of 400 to 500 mL/min and a dialysate flow rate of 800 mL/min [<a href="#rid12">12,30</a>].</p><p>The value of urea clearance in daily hemodialysis has not been clearly established. Other markers, such as phosphorous clearance, may be important as well. In one study, treatment times of three hours per session were associated with improvements in phosphate levels and calcium-phosphorous product [<a href="#rid31">31</a>], which are not consistently seen with shorter treatment times [<a href="#rid32">32</a>].</p><p>As more rigorous studies are conducted in this area, ideal clearance targets for daily hemodialysis will hopefully emerge.</p><p class="headingAnchor" id="H13"><span class="h2">Dialysate composition</span><span class="headingEndMark"> — </span>The dialysate composition used with daily hemodialysis in the manner described above is generally not different from that used with conventional hemodialysis, with the exception of the machines using the low dialysate volume approach (NxStage). The composition of the dialysate is as follows:</p><p class="bulletIndent1"><span class="glyph">●</span>Sodium – 135 to 140 mEq/L</p><p class="bulletIndent1"><span class="glyph">●</span>Potassium – 2 to 3 mEq/L</p><p class="bulletIndent1"><span class="glyph">●</span>Bicarbonate – 35 to 40 mEq/L</p><p class="bulletIndent1"><span class="glyph">●</span>Calcium – 2.5 to 3.5 mEq/L</p><p></p><p class="headingAnchor" id="H14"><span class="h2">Patient monitoring and safety</span><span class="headingEndMark"> — </span>Daily home hemodialysis does not require remote monitoring, since treatments are generally carried out during the daytime and always with the patient awake. Security devices such as enuresis alarms and connector clamps are also generally not needed. Safety issues associated with nocturnal hemodialysis are discussed elsewhere. (See  <a class="medical medical_review" href="/d/html/1904.html" rel="external">"Technical aspects of nocturnal hemodialysis", section on 'Safety'</a>.)</p><p class="headingAnchor" id="H15"><span class="h1">OUTCOMES</span><span class="headingEndMark"> — </span>Multiple observational studies and one randomized trial have shown that more frequent dialysis improves selected outcomes. A benefit on survival has not been shown, although a follow-up for a median of 3.6 years after the completion of the Frequent Hemodialysis Network (FHN) showed a survival advantage of the daily hemodialysis group versus controls (hazard ratio [HR] 0.54, CI 0.31-0.93) [<a href="#rid33">33</a>].</p><p class="headingAnchor" id="H9482545"><span class="h2">Frequent Hemodialysis Network (FHN) daily trial</span><span class="headingEndMark"> — </span>The FHN trial was a multicenter, randomized trial that included 245 patients assigned to either frequent hemodialysis (six times weekly) or conventional hemodialysis [<a href="#rid34">34</a>]. Two primary composite outcomes were determined at one year, including death or one-year change from baseline in left ventricular (LV) mass, as assessed by cardiac resonance imaging, and death or one-year change in physical health, as assessed by a RAND heath survey. Both composite outcomes showed significant benefit to the frequent-dialysis group compared with the conventional-dialysis group (HR 0.61, 95% CI, 0.46-0.82 for death or change in LV mass and HR 0.70, 95% CI, 0.53-0.92 for death or change in physical health).</p><p>This study also demonstrated benefits in predetermined secondary outcomes to the frequent dialysis group, such as a decrease in LV mass, improved blood pressure control, and phosphate balance but not on cognitive performance, depression, serum albumin concentration, or use of erythropoiesis-stimulating agents (ESAs). Post hoc analyses, however, suggested that frequent in-center dialysis led to improved self-reported general mental health [<a href="#rid35">35</a>] and aspects of health-related quality of life including a shorter recovery time after a dialysis session [<a href="#rid35">35,36</a>]. Frequent dialysis reduced LV end-diastolic volume, LV end-systolic volume, and right ventricular (RV) end-diastolic volume but did not affect the ratio between LV mass/LV end-diastolic volume, which is a marker for LV remodelling [<a href="#rid37">37</a>].</p><p class="headingAnchor" id="H9482552"><span class="h2">Observational data</span><span class="headingEndMark"> — </span>Several hundred observational studies have evaluated the various potential benefits and risks of daily hemodialysis. Most have used patients as their own controls, using pre-post comparisons as opposed to parallel control groups. While these studies have been limited by the usual methodologic problems encountered in observational research, they have been instrumental in shaping the way daily hemodialysis is delivered and have shown improvements in a number of important secondary outcomes.</p><p class="headingAnchor" id="H16"><span class="h2">Clearances</span></p><p class="headingAnchor" id="H17"><span class="h3">Urea</span><span class="headingEndMark"> — </span>A discussion of clearances of urea with short daily hemodialysis is presented above. (See <a class="local">'Dialysis prescription and dose monitoring'</a> above and <a class="local">'Measures of adequacy'</a> above.)</p><p class="headingAnchor" id="H18"><span class="h3">Middle molecules</span><span class="headingEndMark"> — </span>In general, middle-molecule removal is determined by the dialyzer permeability, the presence of convection, protein binding, and dialysis duration. Given that daily dialysis results in more frequent solute level equilibration with less rebound, this technique provides higher middle-molecule removal than with conventional hemodialysis, although the reported increase varies by the method of calculation.</p><p class="bulletIndent1"><span class="glyph">●</span>The increased clearance is quantitatively modest if the measurement is based on the time-averaged concentration (TAC) of the solute (as in the calculation of equivalent renal urea clearance [EKR]) [<a href="#rid38">38</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The increased clearance is significant when it is based upon the predialysis concentration of the solute (as in the case of standardized Kt/V [stdKt/V]) [<a href="#rid39">39</a>].</p><p></p><p>By comparison, middle-molecule removal increases significantly by daily nocturnal hemodialysis independent of the calculation method since both time and frequency increase [<a href="#rid38">38-40</a>].</p><p>The serum levels of advanced glycosylation end products also decrease upon conversion from conventional to short (and long nocturnal) hemodialysis [<a href="#rid41">41,42</a>]. However, middle-molecule clearance is better with daily hemofiltration than with daily short hemodialysis [<a href="#rid43">43</a>]. A discussion of middle molecules can be found elsewhere. (See  <a class="medical medical_review" href="/d/html/1916.html" rel="external">"Uremic toxins"</a>.)</p><p class="headingAnchor" id="H19"><span class="h3">Protein-bound molecules</span><span class="headingEndMark"> — </span>In general, protein-bound molecules are not easily removed by dialysis. Although an earlier study suggested that some protein-bound molecules (eg, indole-3-acetic acid, indoxyl sulfate) may be more efficiently cleared with daily, as compared with conventional, hemodialysis [<a href="#rid41">41</a>], the FHN trial showed a limited reduction in plasma levels of such uremic solutes with more intensive hemodialysis [<a href="#rid44">44</a>]. (See  <a class="medical medical_review" href="/d/html/1916.html" rel="external">"Uremic toxins"</a>.)</p><p class="headingAnchor" id="H20"><span class="h3">Phosphate</span><span class="headingEndMark"> — </span>Several studies have shown that short daily hemodialysis improves phosphate balance [<a href="#rid31">31,34,45</a>]. In the FHN daily trial, at one year, compared with the conventional dialysis group, the frequent dialysis group had a lower predialysis serum phosphorus (5.24 versus 5.65, respectively) [<a href="#rid34">34</a>] and a 1.35 g/day reduction in the required equivalent phosphate binder dose [<a href="#rid46">46</a>].</p><p class="headingAnchor" id="H21"><span class="h2">Quality of life</span><span class="headingEndMark"> — </span>Health-related quality of life has been studied using a number of validated instruments. Studies in this area have been mostly positive, with multiple studies showing increases in short form-36 (SF-36) physical or mental component scores [<a href="#rid47">47-53</a>]. One study, for example, demonstrated a significant improvement in utility score (from 0.34 to 0.84), as measured using the time trade-off method after converting from conventional hemodialysis to daily hemodialysis [<a href="#rid48">48</a>]. However, no difference in utility was observed when the Health Utilities Index (HUI) was used.</p><p>A variety of other instruments have shown improvements in or disappearance of uremia and dialysis-related symptoms [<a href="#rid47">47,48,51,54-57</a>].</p><p>In a prospective cohort study (FREEDOM study), among 154 participants (90 percent of whom converted from in-center hemodialysis) who completed an SF-36 health survey at enrollment and at 12 months, there was a sustained improvement in the physical- and mental-component summary scores, as well as in individual domains of the survey [<a href="#rid53">53</a>]. The number of individuals who achieved a physical-component score comparable with the general population more than doubled.</p><p>Among 94 patients with disturbed sleep and/or restless leg syndrome who were included in the FREEDOM study, short daily hemodialysis resulted in a sustained improvement in restless legs symptoms as assessed by the International Restless Leg Syndrome (IRLS) Study Group rating scale [<a href="#rid58">58</a>]. However, the percentage of patients prescribed medication for restless leg syndrome did not decrease.</p><p>After adjusting for restless legs syndrome and the use of related medications, daily hemodialysis was also associated with an improvement in sleep adequacy and disturbances.</p><p class="headingAnchor" id="H22"><span class="h2">Cardiovascular outcomes</span><span class="headingEndMark"> — </span>Improvements in blood pressure control have been observed with short daily hemodialysis [<a href="#rid5">5,47,54,57,59-62</a>]. These include decreases in systolic, diastolic, and/or mean predialysis arterial pressures, with concomitant reductions in blood pressure medication doses [<a href="#rid5">5,34,54,63,64</a>]. In the FHN daily trial, the frequent dialysis group had a lower average predialysis systolic blood pressure compared with the conventional dialysis group at one year (137 versus 147 mmHg, respectively) [<a href="#rid34">34</a>].</p><p>Improvements in blood pressure control also correlate with reductions in LV mass. This was first illustrated in a randomized crossover study of 12 patients in which LV mass fell after six months with daily short hemodialysis (148.7±59.7 g/m<sup>2</sup> during conventional hemodialysis to 120.1±60.4 g/m<sup>2</sup>) [<a href="#rid60">60</a>]. A reduction in LV mass was also shown in the FHN trial; the mean LV mass decreased by 16.4 g in frequent dialysis patients over one year compared with 2.6 g in the controls [<a href="#rid34">34</a>]. Regression of cardiac hypertrophy [<a href="#rid45">45</a>], a decrease in the markers of inflammation (C-reactive protein [CRP]) [<a href="#rid45">45</a>], and a reduction in regional wall motion abnormalities [<a href="#rid65">65</a>] have all been associated with more frequent hemodialysis.</p><p>A concomitant significant reduction in extracellular fluid volume (as measured by bioimpedance spectroscopy) from 52.7±11.4 percent of total body water to 47.6±7.5 percent was also observed. Similarly, the London Daily/Nocturnal Hemodialysis Study found that extracellular fluid volume was lower in daily hemodialysis patients than in matched cohorts receiving conventional hemodialysis [<a href="#rid62">62</a>].</p><p>All of these studies also demonstrated improved blood pressure control [<a href="#rid60">60,62</a>]. This suggests that some of the beneficial antihypertensive effect of daily hemodialysis is related to improved extracellular fluid volume control [<a href="#rid66">66</a>].</p><p>Despite these encouraging findings, the effect of daily hemodialysis on cardiovascular morbidity and mortality has not yet been described in an adequately powered study.</p><p class="headingAnchor" id="H23"><span class="h2">Anemia and erythropoietin dosing</span><span class="headingEndMark"> — </span>The effect of daily hemodialysis on erythropoiesis is uncertain. Some studies report increases in hemoglobin or hematocrit [<a href="#rid54">54,55,59,67</a>], while others have found little change [<a href="#rid5">5,47,60,68,69</a>]. The accurate interpretation of these findings is complicated by the potential for increased surveillance by home dialysis programs, with more aggressive treatment with ESAs and iron and/or more prompt investigation and treatment of iron deficiency in this setting.</p><p>At least three cohorts have required significantly less use of ESAs after converting to daily hemodialysis [<a href="#rid5">5,47,56</a>]. However, most studies have failed to show any significant change in ESA utilization [<a href="#rid34">34</a>]. Increased blood loss through the dialysis circuit resulting in iron deficiency may theoretically mask the potential pro-erythropoietic effects of daily dialysis.</p><p class="headingAnchor" id="H24"><span class="h2">Nutritional effects</span><span class="headingEndMark"> — </span>Daily dialysis may impact a number of nutritional indices. Daily in-center hemodialysis has been used as a rescue therapy for patients with severe malnutrition complicating uremia [<a href="#rid5">5,70</a>], with patients generally reporting increased appetite after switching from conventional to daily hemodialysis. One study, for example, showed an increase in protein intake by 25 percent [<a href="#rid70">70</a>].</p><p>The effects on serum albumin, normalized protein equivalent of nitrogen appearance (nPNA), and dry body weight have been variable, with many studies showing improvements in these parameters and others showing no significant change. Statistical power may have been an issue in some of these negative studies. A secondary analysis of data from the FHN trial cited above showed no difference between patients undergoing frequent versus conventional hemodialysis in serum albumin, protein catabolic rate, or lean body mass [<a href="#rid71">71</a>]. Frequent dialysis was associated with an increase in body weight that was probably due to increased fat.</p><p class="headingAnchor" id="H25"><span class="h2">Hospitalizations</span><span class="headingEndMark"> — </span>Some studies have found a reduction in hospital admissions with daily hemodialysis [<a href="#rid5">5,72</a>]. In one study of 42 patients with a high burden of comorbidity, there was a significant reduction in hospital days from 12.2 patient/year on conventional hemodialysis to 8 patient/year on daily hemodialysis [<a href="#rid5">5</a>]. This was associated with a 40 percent reduction in hospital admissions per patient per year.</p><p>However, no study has demonstrated significant differences in hospitalization rates associated with daily hemodialysis, even when comorbidities are similar to the general hemodialysis patient population. In addition, most studies have lacked adequate statistical power to study the effect of daily hemodialysis on hospitalization rates.</p><p>A nationally representative cohort of 27,430 patients in Canada experienced 111,748 hospitalization episodes over nine years. The probability of a Monday/Tuesday admission was lower for frequent home hemodialysis (HHD) (odds ratio [OR] 0.89, 95% CI 0.81-0.97) and peritoneal dialysis (OR 0.95, 95% CI 0.93-0.97) compared with in-center hemodialysis [<a href="#rid73">73</a>].</p><p>While existing data are encouraging, larger studies with longer periods of follow-up are needed to study this important outcome.</p><p class="headingAnchor" id="H26"><span class="h2">Vascular access</span><span class="headingEndMark"> — </span>More frequent vascular access cannulation required for daily hemodialysis may result in decreased access survival. This issue was addressed in the FHN daily trial, in which the primary vascular outcome was time to first access event (including repair, loss of access, or access-related hospitalization), and the secondary vascular outcome was the time to all repairs and time to all losses [<a href="#rid34">34</a>]. Among all participants (including 198 with a fistula or graft and 47 with a tunneled catheter), the risk for a first access event was higher in the daily group compared with the conventional group (33 repairs and 15 losses versus 17 repairs, 11 losses, and 1 hospitalization, respectively, HR 1.76, 95% CI 1.11–2.79). The increase in risk of a first access event associated with daily dialysis was even greater when patients with a tunneled catheter were excluded from the analysis (HR 1.90, 95% CI 1.1-3.25). Overall, daily dialysis was associated with more access repairs, and 55 percent of all repairs involved thrombectomy [<a href="#rid25">25</a>]. The risk of permanent access loss and of infection did not differ between the groups. These outcomes should be considered when patients are weighing dialysis options [<a href="#rid74">74</a>].</p><p>Other studies have reported access survival comparable to that seen with conventional hemodialysis [<a href="#rid72">72,75</a>]. It is possible that more uniform use of the buttonhole method of cannulating arteriovenous fistulae (AVF) may reduce the number of thrombotic complications associated with daily hemodialysis [<a href="#rid76">76</a>], although infectious complications may be more frequent with this technique [<a href="#rid21">21</a>]. This issue is discussed above. (See <a class="local">'Vascular access'</a> above.)</p><p>We agree with the 2015 Kidney Disease Outcomes Quality Initiative (KDOQI) guidelines that patients who are considering short daily hemodialysis be informed about the possibility of an increase in vascular procedures with this therapy [<a href="#rid9">9</a>].</p><p class="headingAnchor" id="H27"><span class="h2">Cost</span><span class="headingEndMark"> — </span>The few analyses of the economic costs associated with more frequent hemodialysis treatment have demonstrated that overall simulated annual direct healthcare costs are likely to be lower for daily dialysis protocols compared with conventional hemodialysis [<a href="#rid77">77,78</a>]. As an example, higher costs for dialysis consumables are offset by lower costs for hospitalizations and medications. In addition, should the patient receive the therapy at home, an advantage is realized with reduced labor costs that more than offset the capital cost of equipment and renovations provided that the patient remains at home for at least 24 months [<a href="#rid79">79</a>].</p><p>While daily dialysis regimens may be economically attractive from the societal perspective, it may not be appealing from the prospective of the dialysis facility, as the expected cost savings are often realized at other levels of the health care system. Thus, the economics of daily dialysis within current funding mechanisms represents a barrier to widespread adoption of these modalities.</p><p>Larger and better controlled studies are needed to provide additional proof that more frequent hemodialysis can improve clinical parameters and at the same time reduce total health care costs in the long run. A detailed review of the published information regarding the economics of daily hemodialysis can be found elsewhere [<a href="#rid80">80,81</a>].</p><p class="headingAnchor" id="H28"><span class="h2">Survival</span><span class="headingEndMark"> — </span>As noted above, a follow-up for a median of 3.6 years after the completion of the FHN trial showed a survival advantage of the daily hemodialysis group versus controls (HR 0.54, CI 0.31-0.93) [<a href="#rid33">33</a>].</p><p>There are conflicting data from retrospective and observational studies, although most suggest a benefit [<a href="#rid82">82-84</a>]. In the largest observational study, 1873 home hemodialysis patients were compared with 9365 matched in-center patients selected from the United States Renal Data System (USRDS) database [<a href="#rid85">85</a>]. The incidence of death was lower among home hemodialysis patients (19.2 versus 21.7 percent among in-center patients, HR 0.87, 95% CI 0.78-0.97).</p><p>In another retrospective study, 338 patients who were receiving intensive home hemodialysis (mean of 4.8 sessions per week, with a mean treatment time of 7.4 hours per session) were compared with 1338 propensity-matched patients on conventional hemodialysis (mean of three sessions per week, with a mean treatment time of 7.4 hours per session) [<a href="#rid84">84</a>]. Mortality was lower among patients on intensive hemodialysis (13 percent versus 21 percent for control patients on conventional hemodialysis).</p><p>While both studies used rigorous statistical methods and adjusted for most prognostic variables, unmeasured confounders may have contributed to the differences in outcomes. Thus, the association between more frequent hemodialysis and survival requires confirmation in larger clinical trials.</p><p class="headingAnchor" id="H30"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Rationale </strong>– Short daily or "quotidian" hemodialysis consists of daily hemodialysis (five to seven days per week) provided for a duration of 1.5 to 2.5 hours per session. The rationale for this strategy is based upon the premise that improved patient outcomes, compared with conventional three times per week hemodialysis, may occur due to improved dialysis efficiency and hemodynamic stability. (See <a class="local">'Introduction'</a> above and <a class="local">'Overview of rationale'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Practical aspects of daily hemodialysis delivery</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Patient recruitment and selection </strong>– In practice environments where resources limit its use, daily hemodialysis should be prescribed on the basis of need, such as the management of refractory uremic complications, fluid overload, or intractable hypertension. Until large-scale comparative studies are available, the selection of nocturnal versus short daily hemodialysis should largely be dictated by availability and patient preference. (See <a class="local">'Patient recruitment and selection'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Training and education </strong>– Training a home daily hemodialysis patient usually requires a full-time, six-week commitment, although two weeks can be sufficient for a patient with self-care experience. Newer dialysis machines may require shorter training times. (See <a class="local">'Training and education for a home daily hemodialysis patient'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Vascular access </strong>– Native arteriovenous fistulae (AVF), synthetic grafts, and long-term central venous catheters (CVCs) are all acceptable for use in daily hemodialysis. (See <a class="local">'Vascular access'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Equipment and technical aspects </strong>– Although the choice of hemodialysis equipment is wide, it is still based upon the designs of hemodialysis machines that are used in center. Appropriate water treatment must be provided to the home. (See <a class="local">'Equipment and technical aspects'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Dialysis prescription </strong>– A weekly standardized Kt/V (stdKt/V) target of 3 should be sought, which is associated with improvements in a number of physiologic parameters. Modeling indicates that this target is likely to be achievable with a 2.5 hour, six day per week regimen using high-flux, large surface area dialyzers with dialyzer blood flow rates of 400 to 500 mL/min and a dialysate flow rate of 800 mL/min. (See <a class="local">'Dialysis prescription and dose monitoring'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Dialysate composition </strong>– The dialysate composition used with daily hemodialysis is generally not different from that used with conventional hemodialysis. (See <a class="local">'Dialysate composition'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Patient monitoring </strong>– Daily hemodialysis does not require remote monitoring, and security devices such as enuresis alarms and connector clamps are also generally not needed. (See <a class="local">'Patient monitoring and safety'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Outcomes</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Compared with conventional hemodialysis, short daily hemodialysis is associated with increased clearances of urea (based upon stdKt/V), middle molecules, and protein-bound molecules. It may also be associated with a better quality of life, blood pressure control, improved appetite, and decreased rate of hospitalizations. (See <a class="local">'Clearances'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The effect of daily hemodialysis on erythropoiesis is uncertain, with increases in hemoglobin levels being inconsistent. (See <a class="local">'Anemia and erythropoietin dosing'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Overall simulated annual direct health care costs are likely to be lower for daily hemodialysis protocols compared with conventional hemodialysis. (See <a class="local">'Cost'</a> above.)</p><p></p><p class="headingAnchor" id="H2318992978"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>We are saddened by the death of Andreas Pierratos, MD, FRCPC, who passed away in November 2022. UpToDate acknowledges Dr. Pierratos's past work as an author for this topic.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">DePalma JR, Pecker EA, Maxwell MH. A new automatic coil dialyser system for 'daily' dialysis. Proc EDTA 1969; 6:26.</a></li><li><a class="nounderline abstract_t">DePalma JR, Pecker EA, Maxwell MH. A new automatic coil dialyser system for 'daily' dialysis. Semin Dial 1999; 12:410.</a></li><li><a class="nounderline abstract_t">Uldall PR, Francoeur R, Ouwendyk M. Simplified nocturnal home hemodialysis (SNHHD). A new approach to renal replacement therapy. J Am Soc Nephrol 1994; 5:428.</a></li><li><a class="nounderline abstract_t">Pierratos A, Ouwendyk M, Francoeur R, et al. Nocturnal hemodialysis: three-year experience. J Am Soc Nephrol 1998; 9:859.</a></li><li><a class="nounderline abstract_t">Ting GO, Kjellstrand C, Freitas T, et al. Long-term study of high-comorbidity ESRD patients converted from conventional to short daily hemodialysis. Am J Kidney Dis 2003; 42:1020.</a></li><li><a class="nounderline abstract_t">Schiffl H, Lang SM, Fischer R. Daily hemodialysis and the outcome of acute renal failure. N Engl J Med 2002; 346:305.</a></li><li><a class="nounderline abstract_t">Maduell F, del Pozo C, Garcia H, et al. Change from conventional haemodiafiltration to on-line haemodiafiltration. Nephrol Dial Transplant 1999; 14:1202.</a></li><li><a class="nounderline abstract_t">Jaber BL, Zimmerman DL, Teehan GS, et al. Daily hemofiltration for end-stage renal disease: a feasibility and efficacy trial. Blood Purif 2004; 22:481.</a></li><li><a class="nounderline abstract_t">National Kidney Foundation. KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 update. Am J Kidney Dis 2015; 66:884.</a></li><li><a class="nounderline abstract_t">Henderson LW, Leypoldt JK, Lysaght MJ, Cheung AK. Death on dialysis and the time/flux trade-off. Blood Purif 1997; 15:1.</a></li><li><a class="nounderline abstract_t">Gotch FA. The current place of urea kinetic modelling with respect to different dialysis modalities. Nephrol Dial Transplant 1998; 13 Suppl 6:10.</a></li><li><a class="nounderline abstract_t">Suri R, Depner TA, Blake PG, et al. Adequacy of quotidian hemodialysis. Am J Kidney Dis 2003; 42:42.</a></li><li><a class="nounderline abstract_t">Williams AW, Chebrolu SB, Ing TS, et al. Early clinical, quality-of-life, and biochemical changes of "daily hemodialysis" (6 dialyses per week). Am J Kidney Dis 2004; 43:90.</a></li><li><a class="nounderline abstract_t">Bieber SD, Young BA. Home Hemodialysis: Core Curriculum 2021. Am J Kidney Dis 2021; 78:876.</a></li><li><a class="nounderline abstract_t">Leitch R, Ouwendyk M, Ferguson E, et al. Nursing issues related to patient selection, vascular access, and education in quotidian hemodialysis. Am J Kidney Dis 2003; 42:56.</a></li><li><a class="nounderline abstract_t">Twardowski, ZJ. Constant site (buttonhole) method of needle insertion for hemodialysis. Dial Transplant 1995; 24:559.</a></li><li><a class="nounderline abstract_t">van Loon MM, Goovaerts T, Kessels AG, et al. Buttonhole needling of haemodialysis arteriovenous fistulae results in less complications and interventions compared to the rope-ladder technique. Nephrol Dial Transplant 2010; 25:225.</a></li><li><a class="nounderline abstract_t">Hashmi A, Cheema MQ, Moss AH. Hemodialysis patients' experience with and attitudes toward the buttonhole technique for arteriovenous fistula cannulation. Clin Nephrol 2010; 74:346.</a></li><li class="breakAll">Twardowski ZJ, Harper G. Buttonhole method of needle insertion into arteriovenous fistulas. 1997.</li><li><a class="nounderline abstract_t">Twardowski Z, Kubara H. Different sites versus constant sites of needle insertion into arteriovenous fistulas for treatment by repeated dialysis. Dial Transpl 1979; 8:978.</a></li><li><a class="nounderline abstract_t">MacRae JM, Ahmed SB, Atkar R, Hemmelgarn BR. A randomized trial comparing buttonhole with rope ladder needling in conventional hemodialysis patients. Clin J Am Soc Nephrol 2012; 7:1632.</a></li><li><a class="nounderline abstract_t">Zimmerman D, Lok CE. Accessing the access. Clin J Am Soc Nephrol 2012; 7:1548.</a></li><li><a class="nounderline abstract_t">Muir CA, Kotwal SS, Hawley CM, et al. Buttonhole cannulation and clinical outcomes in a home hemodialysis cohort and systematic review. Clin J Am Soc Nephrol 2014; 9:110.</a></li><li><a class="nounderline abstract_t">Moist LM, Nesrallah GE. Should buttonhole cannulation be discontinued? Clin J Am Soc Nephrol 2014; 9:3.</a></li><li><a class="nounderline abstract_t">Suri RS, Larive B, Sherer S, et al. Risk of vascular access complications with frequent hemodialysis. J Am Soc Nephrol 2013; 24:498.</a></li><li><a class="nounderline abstract_t">Vaux E, King J, Lloyd S, et al. Effect of buttonhole cannulation with a polycarbonate PEG on in-center hemodialysis fistula outcomes: a randomized controlled trial. Am J Kidney Dis 2013; 62:81.</a></li><li><a class="nounderline abstract_t">Mehrabian S, Morgan D, Schlaeper C, et al. Equipment and water treatment considerations for the provision of quotidian home hemodialysis. Am J Kidney Dis 2003; 42:66.</a></li><li><a class="nounderline abstract_t">Daugirdas JT. Dialysis adequacy and kinetics. Curr Opin Nephrol Hypertens 2000; 9:599.</a></li><li class="breakAll">Gotch F, personal communication.</li><li><a class="nounderline abstract_t">Suri RS, Depner T, Lindsay RM. Dialysis prescription and dose monitoring in frequent hemodialysis. Contrib Nephrol 2004; 145:75.</a></li><li><a class="nounderline abstract_t">Ayus JC, Achinger SG, Mizani MR, et al. Phosphorus balance and mineral metabolism with 3 h daily hemodialysis. Kidney Int 2007; 71:336.</a></li><li><a class="nounderline abstract_t">Suri RS, Nesrallah GE, Mainra R, et al. Daily hemodialysis: a systematic review. Clin J Am Soc Nephrol 2006; 1:33.</a></li><li><a class="nounderline abstract_t">Chertow GM, Levin NW, Beck GJ, et al. Long-Term Effects of Frequent In-Center Hemodialysis. J Am Soc Nephrol 2016; 27:1830.</a></li><li><a class="nounderline abstract_t">FHN Trial Group, Chertow GM, Levin NW, et al. In-center hemodialysis six times per week versus three times per week. N Engl J Med 2010; 363:2287.</a></li><li><a class="nounderline abstract_t">Unruh ML, Larive B, Chertow GM, et al. Effects of 6-times-weekly versus 3-times-weekly hemodialysis on depressive symptoms and self-reported mental health: Frequent Hemodialysis Network (FHN) Trials. Am J Kidney Dis 2013; 61:748.</a></li><li><a class="nounderline abstract_t">Garg AX, Suri RS, Eggers P, et al. Patients receiving frequent hemodialysis have better health-related quality of life compared to patients receiving conventional hemodialysis. Kidney Int 2017; 91:746.</a></li><li><a class="nounderline abstract_t">Chan CT, Greene T, Chertow GM, et al. Effects of frequent hemodialysis on ventricular volumes and left ventricular remodeling. Clin J Am Soc Nephrol 2013; 8:2106.</a></li><li><a class="nounderline abstract_t">Clark WR, Leypoldt JK, Henderson LW, et al. Quantifying the effect of changes in the hemodialysis prescription on effective solute removal with a mathematical model. J Am Soc Nephrol 1999; 10:601.</a></li><li><a class="nounderline abstract_t">Goldfarb-Rumyantzev AS, Cheung AK, Leypoldt JK. Computer simulation of small-solute and middle-molecule removal during short daily and long thrice-weekly hemodialysis. Am J Kidney Dis 2002; 40:1211.</a></li><li><a class="nounderline abstract_t">Pierratos A. Effect of therapy time and frequency on effective solute removal. Semin Dial 2001; 14:284.</a></li><li><a class="nounderline abstract_t">Floridi A, Antolini F, Galli F, et al. Daily haemodialysis improves indices of protein glycation. Nephrol Dial Transplant 2002; 17:871.</a></li><li><a class="nounderline abstract_t">Cacho C, Erhard P, Priester A, et al. Nocturnal dialysis reduces serum pentosidine in patients with ESRD. Perit Dial Int 2001; 21:S61 [Abstract].</a></li><li><a class="nounderline abstract_t">Leypoldt JK. Solute fluxes in different treatment modalities. Nephrol Dial Transplant 2000; 15 Suppl 1:3.</a></li><li><a class="nounderline abstract_t">Sirich TL, Fong K, Larive B, et al. Limited reduction in uremic solute concentrations with increased dialysis frequency and time in the Frequent Hemodialysis Network Daily Trial. Kidney Int 2017; 91:1186.</a></li><li><a class="nounderline abstract_t">Ayus JC, Mizani MR, Achinger SG, et al. Effects of short daily versus conventional hemodialysis on left ventricular hypertrophy and inflammatory markers: a prospective, controlled study. J Am Soc Nephrol 2005; 16:2778.</a></li><li><a class="nounderline abstract_t">Daugirdas JT, Chertow GM, Larive B, et al. Effects of frequent hemodialysis on measures of CKD mineral and bone disorder. J Am Soc Nephrol 2012; 23:727.</a></li><li><a class="nounderline abstract_t">Traeger J, Galland R, Delawari E, et al. Six years' experience with short daily hemodialysis: do the early improvements persist in the mid and long term? Hemodial Int 2004; 8:151.</a></li><li><a class="nounderline abstract_t">Heidenheim AP, Muirhead N, Moist L, Lindsay RM. Patient quality of life on quotidian hemodialysis. Am J Kidney Dis 2003; 42:36.</a></li><li><a class="nounderline abstract_t">Pinciaroli AR. Results of daily hemodialysis in Catanzaro: a 12-year experience with 22 patients treated for more than 1 year. Home Hemodial Int 1998; 2:12.</a></li><li><a class="nounderline abstract_t">Vos PF, Zilch O, Jennekens-Schinkel A, et al. Effect of short daily home haemodialysis on quality of life, cognitive functioning and the electroencephalogram. Nephrol Dial Transplant 2006; 21:2529.</a></li><li><a class="nounderline abstract_t">Jaber BL, Lee Y, Collins AJ, et al. Effect of daily hemodialysis on depressive symptoms and postdialysis recovery time: interim report from the FREEDOM (Following Rehabilitation, Economics and Everyday-Dialysis Outcome Measurements) Study. Am J Kidney Dis 2010; 56:531.</a></li><li><a class="nounderline abstract_t">Hall YN, Larive B, Painter P, et al. Effects of six versus three times per week hemodialysis on physical performance, health, and functioning: Frequent Hemodialysis Network (FHN) randomized trials. Clin J Am Soc Nephrol 2012; 7:782.</a></li><li><a class="nounderline abstract_t">Finkelstein FO, Schiller B, Daoui R, et al. At-home short daily hemodialysis improves the long-term health-related quality of life. Kidney Int 2012; 82:561.</a></li><li><a class="nounderline abstract_t">Woods JD, Port FK, Orzol S, et al. Clinical and biochemical correlates of starting "daily" hemodialysis. Kidney Int 1999; 55:2467.</a></li><li><a class="nounderline abstract_t">André MB, Rembold SM, Pereira CM, Lugon JR. Prospective evaluation of an in-center daily hemodialysis program: results of two years of treatment. Am J Nephrol 2002; 22:473.</a></li><li><a class="nounderline abstract_t">Koshikawa S, Akizawa T, Saito A, Kurokawa K. Clinical effect of short daily in-center hemodialysis. Nephron Clin Pract 2003; 95:c23.</a></li><li><a class="nounderline abstract_t">Goldfarb-Rumyantzev AS, Leypoldt JK, Nelson N, et al. A crossover study of short daily haemodialysis. Nephrol Dial Transplant 2006; 21:166.</a></li><li><a class="nounderline abstract_t">Jaber BL, Schiller B, Burkart JM, et al. Impact of short daily hemodialysis on restless legs symptoms and sleep disturbances. Clin J Am Soc Nephrol 2011; 6:1049.</a></li><li><a class="nounderline abstract_t">Fagugli RM, Buoncristiani U, Ciao G. Anemia and blood pressure correction obtained by daily hemodialysis induce a reduction of left ventricular hypertrophy in dialysed patients. Int J Artif Organs 1998; 21:429.</a></li><li><a class="nounderline abstract_t">Fagugli RM, Reboldi G, Quintaliani G, et al. Short daily hemodialysis: blood pressure control and left ventricular mass reduction in hypertensive hemodialysis patients. Am J Kidney Dis 2001; 38:371.</a></li><li><a class="nounderline abstract_t">Piccoli GB, Bermond F, Mezza E, et al. Vascular access survival and morbidity on daily dialysis: a comparative analysis of home and limited care haemodialysis. Nephrol Dial Transplant 2004; 19:2084.</a></li><li><a class="nounderline abstract_t">Nesrallah G, Bergman A, Heidenheim AP, et al. Short-hours daily and slow nocturnal hemodialysis improve blood pressure control: Are the mechanisms the same? J Am Soc Nephrol 2001; 12:273 [Abstract].</a></li><li><a class="nounderline abstract_t">Al-Hejaili F, Kortas C, Leitch R, et al. Nocturnal but not short hours quotidian hemodialysis requires an elevated dialysate calcium concentration. J Am Soc Nephrol 2003; 14:2322.</a></li><li><a class="nounderline abstract_t">Kooistra MP, Vos J, Koomans HA, Vos PF. Daily home haemodialysis in The Netherlands: effects on metabolic control, haemodynamics, and quality of life. Nephrol Dial Transplant 1998; 13:2853.</a></li><li><a class="nounderline abstract_t">Jefferies HJ, Virk B, Schiller B, et al. Frequent hemodialysis schedules are associated with reduced levels of dialysis-induced cardiac injury (myocardial stunning). Clin J Am Soc Nephrol 2011; 6:1326.</a></li><li><a class="nounderline abstract_t">Zilch O, Vos PF, Oey PL, et al. Sympathetic hyperactivity in haemodialysis patients is reduced by short daily haemodialysis. J Hypertens 2007; 25:1285.</a></li><li><a class="nounderline abstract_t">Piccoli GB, Mezza E, Quaglia M, et al. Flexibility as an implementation strategy for a daily dialysis program. J Nephrol 2003; 16:365.</a></li><li><a class="nounderline abstract_t">Rao M, Muirhead N, Klarenbach S, et al. Management of anemia with quotidian hemodialysis. Am J Kidney Dis 2003; 42:18.</a></li><li><a class="nounderline abstract_t">Ornt DB, Larive B, Rastogi A, et al. Impact of frequent hemodialysis on anemia management: results from the Frequent Hemodialysis Network (FHN) Trials. Nephrol Dial Transplant 2013; 28:1888.</a></li><li><a class="nounderline abstract_t">Galland R, Traeger J, Arkouche W, et al. Short daily hemodialysis and nutritional status. Am J Kidney Dis 2001; 37:S95.</a></li><li><a class="nounderline abstract_t">Kaysen GA, Greene T, Larive B, et al. The effect of frequent hemodialysis on nutrition and body composition: frequent Hemodialysis Network Trial. Kidney Int 2012; 82:90.</a></li><li><a class="nounderline abstract_t">Martins Castro MC, Luders C, Elias RM, et al. High-efficiency short daily haemodialysis--morbidity and mortality rate in a long-term study. Nephrol Dial Transplant 2006; 21:2232.</a></li><li><a class="nounderline abstract_t">Tennankore KK, Nadeau-Fredette AC, Matheson K, et al. Home versus In-Center Dialysis and Day of the Week Hospitalization: A Cohort Study. Kidney360 2022; 3:103.</a></li><li><a class="nounderline abstract_t">Berns JS, Dember LM. Can frequent hemodialysis be too frequent? J Am Soc Nephrol 2013; 24:334.</a></li><li><a class="nounderline abstract_t">Quintaliani G, Buoncristiani U, Fagugli R, et al. Survival of vascular access during daily and three times a week hemodialysis. Clin Nephrol 2000; 53:372.</a></li><li><a class="nounderline abstract_t">Twardowski ZJ, Misra M. "Daily" dialysis--lessons from a randomized, controlled trial. N Engl J Med 2010; 363:2363.</a></li><li><a class="nounderline abstract_t">Mohr PE, Neumann PJ, Franco SJ, et al. The case for daily dialysis: its impact on costs and quality of life. Am J Kidney Dis 2001; 37:777.</a></li><li><a class="nounderline abstract_t">McFarlane PA, Pierratos A, Redelmeier DA. Cost savings of home nocturnal versus conventional in-center hemodialysis. Kidney Int 2002; 62:2216.</a></li><li><a class="nounderline abstract_t">Ting G, Carrie B, Freitas T, Zarghamee S. Global ESRD Costs Associated with a Short Daily Hemodialysis Program in the United States. Home Hemodial Int 1999; 3:41.</a></li><li><a class="nounderline abstract_t">Kroeker A, Clark WF, Heidenheim AP, et al. Costs of Quotidian Home Hemodialysis. Hemodial Int 2003; 7:73.</a></li><li><a class="nounderline abstract_t">Kroeker A, Clark WF, Heidenheim AP, et al. An operating cost comparison between conventional and home quotidian hemodialysis. Am J Kidney Dis 2003; 42:49.</a></li><li><a class="nounderline abstract_t">Kjellstrand CM, Buoncristiani U, Ting G, et al. Short daily haemodialysis: survival in 415 patients treated for 1006 patient-years. Nephrol Dial Transplant 2008; 23:3283.</a></li><li><a class="nounderline abstract_t">Johansen KL, Zhang R, Huang Y, et al. Survival and hospitalization among patients using nocturnal and short daily compared to conventional hemodialysis: a USRDS study. Kidney Int 2009; 76:984.</a></li><li><a class="nounderline abstract_t">Nesrallah GE, Lindsay RM, Cuerden MS, et al. Intensive hemodialysis associates with improved survival compared with conventional hemodialysis. J Am Soc Nephrol 2012; 23:696.</a></li><li><a class="nounderline abstract_t">Weinhandl ED, Liu J, Gilbertson DT, et al. Survival in daily home hemodialysis and matched thrice-weekly in-center hemodialysis patients. J Am Soc Nephrol 2012; 23:895.</a></li></ol></div><div id="topicVersionRevision">Topic 1898 Version 42.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : A new automatic coil dialyser system for 'daily' dialysis</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : A new automatic coil dialyser system for 'daily' dialysis</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Simplified nocturnal home hemodialysis (SNHHD). A new approach to renal replacement therapy</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9596084" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Nocturnal hemodialysis: three-year experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14582046" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Long-term study of high-comorbidity ESRD patients converted from conventional to short daily hemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11821506" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Daily hemodialysis and the outcome of acute renal failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10344362" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Change from conventional haemodiafiltration to on-line haemodiafiltration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15523174" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Daily hemofiltration for end-stage renal disease: a feasibility and efficacy trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26498416" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 update.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9096902" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Death on dialysis and the time/flux trade-off.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9719197" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : The current place of urea kinetic modelling with respect to different dialysis modalities.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12830443" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Adequacy of quotidian hemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14712432" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Early clinical, quality-of-life, and biochemical changes of "daily hemodialysis" (6 dialyses per week).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34518031" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Home Hemodialysis: Core Curriculum 2021.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12830445" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Nursing issues related to patient selection, vascular access, and education in quotidian hemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Constant site (buttonhole) method of needle insertion for hemodialysis</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19717827" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Buttonhole needling of haemodialysis arteriovenous fistulae results in less complications and interventions compared to the rope-ladder technique.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20979942" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Hemodialysis patients' experience with and attitudes toward the buttonhole technique for arteriovenous fistula cannulation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20979942" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Hemodialysis patients' experience with and attitudes toward the buttonhole technique for arteriovenous fistula cannulation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Different sites versus constant sites of needle insertion into arteriovenous fistulas for treatment by repeated dialysis</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22822010" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : A randomized trial comparing buttonhole with rope ladder needling in conventional hemodialysis patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22977211" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Accessing the access.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24370768" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Buttonhole cannulation and clinical outcomes in a home hemodialysis cohort and systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24370766" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Should buttonhole cannulation be discontinued?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23393319" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Risk of vascular access complications with frequent hemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23473984" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Effect of buttonhole cannulation with a polycarbonate PEG on in-center hemodialysis fistula outcomes: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12830447" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Equipment and water treatment considerations for the provision of quotidian home hemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11128421" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Dialysis adequacy and kinetics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11128421" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Dialysis adequacy and kinetics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15496794" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Dialysis prescription and dose monitoring in frequent hemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17191084" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Phosphorus balance and mineral metabolism with 3 h daily hemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17699188" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Daily hemodialysis: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26467779" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Long-Term Effects of Frequent In-Center Hemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21091062" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : In-center hemodialysis six times per week versus three times per week.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23332990" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Effects of 6-times-weekly versus 3-times-weekly hemodialysis on depressive symptoms and self-reported mental health: Frequent Hemodialysis Network (FHN) Trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28094031" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Patients receiving frequent hemodialysis have better health-related quality of life compared to patients receiving conventional hemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23970131" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Effects of frequent hemodialysis on ventricular volumes and left ventricular remodeling.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10073611" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Quantifying the effect of changes in the hemodialysis prescription on effective solute removal with a mathematical model.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12460040" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Computer simulation of small-solute and middle-molecule removal during short daily and long thrice-weekly hemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11489204" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Effect of therapy time and frequency on effective solute removal.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11981076" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Daily haemodialysis improves indices of protein glycation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Nocturnal dialysis reduces serum pentosidine in patients with ESRD</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10737159" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Solute fluxes in different treatment modalities.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28089366" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Limited reduction in uremic solute concentrations with increased dialysis frequency and time in the Frequent Hemodialysis Network Daily Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16033855" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Effects of short daily versus conventional hemodialysis on left ventricular hypertrophy and inflammatory markers: a prospective, controlled study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22362907" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Effects of frequent hemodialysis on measures of CKD mineral and bone disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19379411" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Six years' experience with short daily hemodialysis: do the early improvements persist in the mid and long term?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12830442" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Patient quality of life on quotidian hemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Results of daily hemodialysis in Catanzaro: a 12-year experience with 22 patients treated for more than 1 year</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16720589" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Effect of short daily home haemodialysis on quality of life, cognitive functioning and the electroencephalogram.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20673601" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Effect of daily hemodialysis on depressive symptoms and postdialysis recovery time: interim report from the FREEDOM (Following Rehabilitation, Economics and Everyday-Dialysis Outcome Measurements) Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22422538" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Effects of six versus three times per week hemodialysis on physical performance, health, and functioning: Frequent Hemodialysis Network (FHN) randomized trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22622497" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : At-home short daily hemodialysis improves the long-term health-related quality of life.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10354296" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Clinical and biochemical correlates of starting "daily" hemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12381946" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Prospective evaluation of an in-center daily hemodialysis program: results of two years of treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14520018" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Clinical effect of short daily in-center hemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16169869" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : A crossover study of short daily haemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21415315" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Impact of short daily hemodialysis on restless legs symptoms and sleep disturbances.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9746000" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Anemia and blood pressure correction obtained by daily hemodialysis induce a reduction of left ventricular hypertrophy in dialysed patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11479164" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Short daily hemodialysis: blood pressure control and left ventricular mass reduction in hypertensive hemodialysis patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15213323" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Vascular access survival and morbidity on daily dialysis: a comparative analysis of home and limited care haemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Short-hours daily and slow nocturnal hemodialysis improve blood pressure control: Are the mechanisms the same?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12937309" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Nocturnal but not short hours quotidian hemodialysis requires an elevated dialysate calcium concentration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9829490" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Daily home haemodialysis in The Netherlands: effects on metabolic control, haemodynamics, and quality of life.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21597028" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Frequent hemodialysis schedules are associated with reduced levels of dialysis-induced cardiac injury (myocardial stunning).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17563543" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Sympathetic hyperactivity in haemodialysis patients is reduced by short daily haemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12832735" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Flexibility as an implementation strategy for a daily dialysis program.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12830439" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Management of anemia with quotidian hemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23358899" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Impact of frequent hemodialysis on anemia management: results from the Frequent Hemodialysis Network (FHN) Trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11158870" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Short daily hemodialysis and nutritional status.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22456602" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : The effect of frequent hemodialysis on nutrition and body composition: frequent Hemodialysis Network Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16632557" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : High-efficiency short daily haemodialysis--morbidity and mortality rate in a long-term study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35368556" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Home versus In-Center Dialysis and Day of the Week Hospitalization: A Cohort Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23411783" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Can frequent hemodialysis be too frequent?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11305810" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Survival of vascular access during daily and three times a week hemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21091061" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : "Daily" dialysis--lessons from a randomized, controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11273878" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : The case for daily dialysis: its impact on costs and quality of life.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12427148" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Cost savings of home nocturnal versus conventional in-center hemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28455855" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Global ESRD Costs Associated with a Short Daily Hemodialysis Program in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Costs of Quotidian Home Hemodialysis</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12830444" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : An operating cost comparison between conventional and home quotidian hemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18458034" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Short daily haemodialysis: survival in 415 patients treated for 1006 patient-years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19692997" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Survival and hospitalization among patients using nocturnal and short daily compared to conventional hemodialysis: a USRDS study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22362910" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Intensive hemodialysis associates with improved survival compared with conventional hemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22362906" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Survival in daily home hemodialysis and matched thrice-weekly in-center hemodialysis patients.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
